insights

Deal Terms Analysis

Expert insights into M&A deal terms and key trends.

Filter

Format

Deal Terms Analysis

2025 Working Capital Purchase Price Adjustment Study

Deal Terms Analysis

Life Sciences

Bio/Pharma M&A: Earnout Achievement Insights

Deal Terms Analysis

M&A Deal Terms: Three Trends to Watch in 2025

Deal Terms Analysis

2024 Trends in M&A Indemnification Claims and Earnouts

Deal Terms Analysis

Lower Middle Market M&A Deals: What Makes Them Different?

Deal Terms Analysis

2024 M&A Deal Terms Special Report: Lower Middle-Market Deals

Deal Terms Analysis

2024 M&A Claims Insights Report

Indemnification

Deal Terms Analysis

2024 RWI Highlights: Effect of Reps and Warranties Insurance on M&A Deal Terms

Deal Terms Analysis

2024 M&A Deal Terms: Highlights for M&A Advisors

Deal Terms Analysis

Indemnification

Deal Terms for M&A Escrows - Statistics and Key Findings

Deal Terms Analysis

2024 M&A Deal Terms Study

Deal Terms Analysis

2024 M&A Working Capital PPA Study

Deal Terms Analysis

M&A Earnouts: Be Prepared for 2024

Shareholder Representation

Deal Terms Analysis

M&A Purchase Price Adjustments Are Common Yet Complex

Deal Terms Analysis

Valuation Disconnects Driving a Spike in Earnouts in M&A

Deal Terms Analysis

Lower Middle-Market Mergers & Acquisitions Deals Report

Deal Terms Analysis

Life Sciences

2023 SRS Acquiom Life Sciences M&A Study

Deal Terms Analysis

2023 M&A Deal Terms and Trends for Private Equity Buyers

Deal Terms Analysis

Technology M&A Deal Terms and Trends

Deal Terms Analysis

Indemnification

Effect of Representations and Warranties Insurance on Deal Terms

Deal Terms Analysis

Private M&A Deal Terms: An SRS Acquiom Quick Guide for M&A Advisors

Deal Terms Analysis

Tools and Tactics for Getting Deals Across the Finish Line

Deal Terms Analysis

2023 M&A Deal Terms Study

Deal Terms Analysis

M&A Trends: PPAs and Claims Activity